Impact of Nutrition on Bronchopulmonary Dysplasia

Clinics in Perinatology

Volumn 42, Issue 4, 2015, Pages 797-806

  Poindexter, Brenda B ^a   Martin, Camilia R ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bronchopulmonary dysplasia; Growth; Nutrition; Premature infants

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LONG CHAIN FATTY ACID; POLYUNSATURATED FATTY ACID; RETINOL; VITAMIN D;

CALORIC INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY EXPENDITURE; FAT INTAKE; FLUID INTAKE; GROWTH DISORDER; HIGH RISK INFANT; HUMAN; INCIDENCE; INFANT NUTRITION; INTRAUTERINE GROWTH RETARDATION; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; NONHUMAN; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; SMALL FOR DATE INFANT; VITAMIN SUPPLEMENTATION; BRONCHOPULMONARY DYSPLASIA; CHILD DEVELOPMENT; DIETARY SUPPLEMENT; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; NEWBORN; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PREMATURITY; PROCEDURES;

BRONCHOPULMONARY DYSPLASIA; CHILD DEVELOPMENT; DIETARY SUPPLEMENTS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NUTRITIONAL STATUS; PARENTERAL NUTRITION;

EID: 84947615133     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2015.08.007     Document Type: Review

References (52)

1. Fanaroff A.A., Stoll B.J., Wright L.L., et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007, 196(2):147.e1-147.e8.
2. Reiss I., Landmann E., Heckmann M., et al. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch Gynecol Obstet 2003, 269(1):40-44.
3. Eriksson L., Haglund B., Odlind V., et al. Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia. Acta Paediatr 2015, 104(3):259-263.
4. Bose C., Van Marter L.J., Laughon M., et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 2009, 124(3):e450-e458.
5. Rozance P.J., Seedorf G.J., Brown A., et al. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011, 301(6):L860-L871.
6. Poindexter B, Langer J, Hintz S, et al. Have we caught up? Growth and neurodevelopmental outcomes in extremely premature infants. Pediatric Academic Societies annual meeting. 2013. 1395.2.
7. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126(3):443-456.
8. Olsen I.E., Groveman S.A., Lawson M.L., et al. New intrauterine growth curves based on United States data. Pediatrics 2010, 125(2):e214-e224.
9. Clark R.H., Thomas P., Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics 2003, 111(5 Pt 1):986-990.
10. Ehrenkranz R.A., Dusick A.M., Vohr B.R., et al. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006, 117(4):1253-1261.
11. Ehrenkranz R.A. Nutrition, growth and clinical outcomes. World Rev Nutr Diet 2014, 110:11-26.
12. Ramel S.E., Demerath E.W., Gray H.L., et al. The relationship of poor linear growth velocity with neonatal illness and two-year neurodevelopment in preterm infants. Neonatology 2012, 102(1):19-24.
13. Vohr B.R., Bell E.F., Oh W. Infants with bronchopulmonary dysplasia. Growth pattern and neurologic and developmental outcome. Am J Dis Child 1982, 136(5):443-447.
14. Markestad T., Fitzhardinge P.M. Growth and development in children recovering from bronchopulmonary dysplasia. J Pediatr 1981, 98(4):597-602.
15. Davidson S., Schrayer A., Wielunsky E., et al. Energy intake, growth, and development in ventilated very-low-birth-weight infants with and without bronchopulmonary dysplasia. Am J Dis Child 1990, 144(5):553-559.
16. Huysman W.A., de Ridder M., de Bruin N.C., et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2003, 88(1):F46-F51.
17. Ehrenkranz R.A., Das A., Wrage L.A., et al. Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res 2011, 69(6):522-529.
18. Poindexter B. Approaches to growth faltering. World Rev Nutr Diet 2014, 110:228-238.
19. Beam K.S., Aliaga S., Ahlfeld S.K., et al. A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J Perinatol 2014, 34(9):705-710.
20. Tyson J.E., Wright L.L., Oh W., et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999, 340(25):1962-1968.
21. Pearson E., Bose C., Snidow T., et al. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. J Pediatr 1992, 121(3):420-427.
22. Kennedy K.A., Stoll B.J., Ehrenkranz R.A., et al. Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? The NICHD Neonatal Research Network. Early Hum Dev 1997, 49(1):19-31.
23. Ambalavanan N., Tyson J.E., Kennedy K.A., et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics 2005, 115(3):e249-e254.
24. Oh W., Poindexter B.B., Perritt R., et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2005, 147(6):786-790.
25. Wassner S.J. Altered growth and protein turnover in rats fed sodium-deficient diets. Pediatr Res 1989, 26(6):608-613.
26. Leitch C.A., Ahlrichs J., Karn C., et al. Energy expenditure and energy intake during dexamethasone therapy for chronic lung disease. Pediatr Res 1999, 46(1):109-113.
27. Senterre T., Rigo J. Optimizing early nutritional support based on recent recommendations in VLBW infants and postnatal growth restriction. J Pediatr Gastroenterol Nutr 2011, 53(5):536-542.
28. Martin C.R., Brown Y.F., Ehrenkranz R.A., et al. Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics 2009, 124(2):649-657.
29. Koletzko B., Poindexter B., Uauy R. Recommended nutrient intake levels for stable, fully enterally fed very low birth weight infants. World Rev Nutr Diet 2014, 110:297-299.
30. Forsyth J.S., Crighton A. Low birthweight infants and total parenteral nutrition immediately after birth. I. Energy expenditure and respiratory quotient of ventilated and non-ventilated infants. Arch Dis Child Fetal Neonatal Ed 1995, 73(1):F4-F7.
31. Groothuis J.R., Makari D. Definition and outpatient management of the very low-birth-weight infant with bronchopulmonary dysplasia. Adv Ther 2012, 29(4):297-311.
32. Bancalari E., Wilson-Costello D., Iben S.C. Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev 2005, 81(2):171-179.
33. Carlson S.J. Current nutrition management of infants with chronic lung disease. Nutr Clin Pract 2004, 19(6):581-586.
34. Carver J.D. Nutrition for preterm infants after hospital discharge. Adv Pediatr 2005, 52:23-47.
35. Brunton J.A., Saigal S., Atkinson S.A. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J Pediatr 1998, 133(3):340-345.
36. Bott L., Béghin L., Devos P., et al. Nutritional status at 2 years in former infants with bronchopulmonary dysplasia influences nutrition and pulmonary outcomes during childhood. Pediatr Res 2006, 60(3):340-344.
37. Brands B., Demmelmair H., Koletzko B., et al. How growth due to infant nutrition influences obesity and later disease risk. Acta Paediatr 2014, 103(6):578-585.
38. Lapillonne A., Griffin I.J. Feeding preterm infants today for later metabolic and cardiovascular outcomes. J Pediatr 2013, 162(3 Suppl):S7-S16.
39. Maden M., Hind M. Retinoic acid in alveolar development, maintenance and regeneration. Philos Trans R Soc Lond B Biol Sci 2004, 359(1445):799-808.
40. Londhe V.A., Maisonet T.M., Lopez B., et al. Retinoic acid rescues alveolar hypoplasia in the calorie-restricted developing rat lung. Am J Respir Cell Mol Biol 2013, 48(2):179-187.
41. Kaplan H.C., Tabangin M.E., McClendon D., et al. Understanding variation in vitamin A supplementation among NICUs. Pediatrics 2010, 126(2):e367-e373.
42. Lykkedegn S., Sorensen G.L., Beck-Nielsen S.S., et al. The impact of vitamin D on fetal and neonatal lung maturation. A systematic review. Am J Physiol Lung Cell Mol Physiol 2015, 308(7):L587-L602.
43. Mandell E., Seedorf G., Gien J., et al. Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2014, 306(5):L420-L428.
44. Hallman M., Jarvenpaa A.L., Pohjavuori M. Respiratory distress syndrome and inositol supplementation in preterm infants. Arch Dis Child 1986, 61(11):1076-1083.
45. Hallman M., Bry K., Hoppu K., et al. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med 1992, 326(19):1233-1239.
46. Hallman M., Pohjavuori M., Bry K. Inositol supplementation in respiratory distress syndrome. Lung 1990, 168(Suppl):877-882.
47. Martin C.R., Zaman M.M., Gilkey C., et al. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. PLoS One 2014, 9(6):e98773.
48. Ma L., Li N., Liu X., et al. Arginyl-glutamine dipeptide or docosahexaenoic acid attenuate hyperoxia-induced lung injury in neonatal mice. Nutrition 2012, 28(11-12):1186-1191.
49. Rogers L.K., Valentine C.J., Pennell M., et al. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr 2011, 141(2):214-222.
50. Martin C.R., Dasilva D.A., Cluette-Brown J.E., et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr 2011, 159(5):743-749.e2.
51. Manley B.J., Makrides M., Collins C.T., et al. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics 2011, 128(1):e71-e77.
52. Skouroliakou M., Konstantinou D., Agakidis C., et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/omega-3-PUFA-containing or soybean-based lipid emulsions. Nutr Clin Pract 2012, 27(6):817-824.